Recent headlines concerning sexually transmitted diarrhea have driven public interest toward shigellosis, an intestinal infection caused by Shigella bacteria. While social media discussions suggest a major outbreak, data from the Centers for Disease Control and Prevention show that reported case counts remain stable compared to previous years.
The conversation surrounding shigellosis has gained momentum online, frequently framing the condition under the label of sexually transmitted diarrhea. The bacterium typically lives in stool and transmits through microscopic fecal particles during sexual practices such as anal sex, oral-anal contact, or other forms of close contact. While the terminology is not an official medical diagnosis, sexual contact is a major transmission route for the bacteria in the United States.
Shigella consists of a group of bacteria that infect the digestive system, with Shigella sonnei serving as the most prevalent strain domestically. The infection triggers acute symptoms including watery or bloody diarrhea, fever, stomach cramps, and a persistent urge to pass stool even when the bowels are empty. Symptoms generally manifest one to two days following exposure and persist for five to seven days, though bacterial shedding can continue for up to two weeks after symptoms resolve.
In Plain English: The Clinical Takeaway
- Fecal-Oral Transmission: Shigella spreads through microscopic amounts of stool transferred via hands, surfaces, contaminated water, or sexual contact involving the anal area.
- Symptom Management: Most individuals recover with rest and hydration; anti-diarrheal medicines may make some Shigella infections worse.
- Transmission Window: Individuals are advised to abstain from sexual activity for at least two weeks after diarrhea stops to prevent spreading the bacteria.
Tracking Shigellosis Case Numbers Across the United States
Public apprehension has been fueled by reports describing a major surge in infections. However, federal health data indicates otherwise. The CDC recorded 13,921 shigellosis cases nationwide as of Sept. 26, 2026, tracking closely with the 14,277 cases reported in all of 2025. While the CDC estimates roughly 450,000 total annual infections due to underreporting, current infection rates reflect a stable epidemiological pattern rather than an exploding outbreak.
Historically, shigellosis spread primarily through contaminated food and water supplies, international travel, or childcare settings. Since the early 2000s, however, clinicians have documented sustained transmission among adult populations, notably among gay, bisexual, and other men who have sex with men. People living with HIV and young children also face elevated risks of acquiring more severe forms of the illness.
Antibiotic Resistance Patterns and Extensively Drug-Resistant Strains
The more pressing clinical challenge involves antimicrobial resistance rather than total case volume. Bacteria continuously evolve mechanisms to survive pharmaceutical treatments, particularly when medications are overused or misused. Certain Shigella strains have demonstrated a marked capacity to withstand multiple standard therapies.
Federal surveillance data highlights a concerning upward trajectory in resistant pathogens. In 2011, only about 3% of tested Shigella samples showed resistance to azithromycin. By 2017, that figure climbed to 24%. A CDC report released in April documented that extensively drug-resistant cases—meaning the bacteria resist all FDA-approved antibiotics, including ampicillin, ciprofloxacin, and trimethoprim-sulfamethoxazole—rose from 0% of tested samples in 2011 to 8.5% by 2023. A significant majority of these resistant infections occurred in adult males who had no history of international travel, pointing to local community acquisition.
| Metric | 2011 Baseline | Recent Data |
|---|---|---|
| Azithromycin Resistance | ~3% | 24% (2017) |
| Extensively Drug-Resistant Strains | 0% | 8.5% (2023) |
| Annual U.S. Case Count (CDC) | N/A | 13,921 (as of Sept. 26, 2026) |
Contraindications & When to Consult a Doctor
Healthcare professionals utilize laboratory tests to identify specific antibiotic sensitivities before prescribing treatment, avoiding ineffective therapies that could exacerbate bacterial resistance. Anti-diarrheal medications may make some Shigella infections worse. To reduce transmission risk, preventive hygiene measures include thorough handwashing with soap and water and abstaining from sexual contact for two weeks following the complete cessation of diarrhea.
References
- Centers for Disease Control and Prevention (CDC) — Shigella Overview
- Centers for Disease Control and Prevention — Surveillance Data
